(Somerset, N.J.) Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, has announced three new appointments to its Development and Clinical Services business unit. Paul Wituschek has joined as the Vice President of Sales for the Development and Clinical Services business unit. Sven Lee will lead the Biologics sales team as the Vice President of Business Development. Dr. Paul Ingram is appointed to the newly created role of European Sales Director for Clinical Supply Services. Catalent is continuing to invest in building strong customer focus through the addition of these three sales veterans with outstanding, specialized industry experience. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, announced that it is enhancing a global network of Catalent sourcing specialists to supply comparator drugs directly from manufacturers, thereby reducing customer costs and ensuring timely initiation and reliability of product supply. (more…)

(Research Triangle Park, N.C.) Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be leading a pre-conference workshop entitled “Fit for Purpose Bioassay Development & Validation” at the 9th Annual Biological Assays Conference in London on November 2, 2010. The conference is designed to improve the development, validation and analysis of biological assays by exposing biopharmaceutical professionals to detailed case studies from fellow peers. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions is pleased to announce that the Optiform™ compound optimization platform, a novel, solid-state and highly-automated analysis platform for salt, crystal-form, and co-crystal screening, developed and refined over the past ten years within GlaxoSmithKline (GSK) will now be broadly available to early development scientists for the first time.  The technology has resulted in faster and more material-efficient development workflows, making it easier to bring new drugs to market faster. The Optiform™ compound optimization platform has been applied to more than 500 compounds, spanning from early stage lead compounds through launched products.  GSK has entered into an agreement with Catalent to utilize the Optiform™ platform to support its internal screening activities. The deal between Catalent and GSK was brokered by SR One, GSK’s corporate venture fund. (more…)

(Research Triangle Park, N.C.) Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, has been invited by the Taiwan Biotech Organization to lead a one-day workshop on GMP Bioassay Validation and GLP Immunogenicity Method Development on July 28, 2010. Dr. Menendez will also be delivering a podium presentation titled “Effective Transfer of Complex Biological Method” at the Key Technology Forum in Protein Drug Development, July 29, 2010. The Forum will focus on upstream process development, downstream process development, analytical and bioassay method development, formulation development and manufacturing, facility construction, and quality assurance and regulatory issues. (more…)

(Research Triangle Park, N.C.) Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be leading an interactive pre-conference workshop titled, “Immunogenicity Programs: Not Just Another Box to Check” at the 6th Annual Global Proteins Summit in London, UK. The workshop will be held on June 22 at 12:30pm. The Summit brings together experts from all over the world, presenting the latest developments in protein therapeutics, cell culture expression and immunogenicity. (more…)

(Research Triangle Park, N.C.) Gregory T. Bleck, PhD., Senior Director of Cell Line Engineering for Catalent Pharma Solutions, will lead a webinar on the characteristics of effective mammalian cell line generation process for bio-pharmaceutical production on May 25, 2010 at 2pm EDT. To register for this complimentary webinar please visit: https://www2.gotomeeting.com/register/853525658. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions’ industry experts will deliver scientific poster presentations this month at the 2010 AAPS National Biotechnology Conference, May 16-19 in San Francisco, California. This week of educational programming is dedicated to advancing health through innovations in biotherapeutics. Catalent is a sustaining sponsor of the 2010 AAPS National Biotechnology Conference. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions will host a free Webinar featuring Senior Manager, Wei Pan, Ph.D. RAC and Kathy Waddle, Director, Stability QC Biology.  The one-hour Webinar will cover stability studies as a critical part of the drug development process and the vital role they play for drug product marketing approval.  The Webinar, titled “Stability Studies in Pharmaceutical Development,” will be held on Tuesday, November 20, 2009 at 2 p.m. (EST). To register for the Webinar please visit: https://www2.gotomeeting.com/register/280747146. (more…)

(Research Triangle Park, N.C.) An article co-authored by Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, has been selected for the Jack L. Beal Award as best paper for 2008 by the American Chemical Society’s (ACS) Journal of Natural Products. The winning article is titled “Isolation and Structure Determination of Malevamide E, a Dolastatin 14 Analogue, from the Marine Cyanobacterium Symploca laete-viridis” and is the structure elucidation of a peptide from a marine cyanobacterium. (more…)